ARCHIVES

Immune Therapy Possible For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Trial Shows Standard-Dose Radiotherapy Safer, More Effective than Higher Doses

May 31, 2013

Harkin Withdraws Amendment Allow NIH To Bypass INDS

October 9, 1992

ACCC Unit Reaches Consensus On Outline of HOP; Each Member Would Relate To Center Or Cooperative Group

September 11, 1981

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

NCI prepares for third hearing on conflicts of interest.

June 18, 2004